Waters Co. (NYSE:WAT – Free Report) – Analysts at KeyCorp reduced their Q3 2023 earnings estimates for shares of Waters in a note issued to investors on Wednesday, August 2nd. KeyCorp analyst P. Knight now expects that the medical instruments supplier will earn $2.58 per share for the quarter, down from their previous estimate of $2.90. The consensus estimate for Waters’ current full-year earnings is $12.25 per share. KeyCorp also issued estimates for Waters’ FY2023 earnings at $12.20 EPS, FY2024 earnings at $13.30 EPS and FY2025 earnings at $15.00 EPS.
Waters (NYSE:WAT – Get Free Report) last posted its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $2.80 EPS for the quarter, topping the consensus estimate of $2.59 by $0.21. Waters had a net margin of 22.54% and a return on equity of 141.19%. The firm had revenue of $740.58 million during the quarter, compared to analysts’ expectations of $733.51 million.
Waters Price Performance
NYSE WAT opened at $289.94 on Friday. Waters has a 52 week low of $248.18 and a 52 week high of $353.70. The company has a current ratio of 2.21, a quick ratio of 1.59 and a debt-to-equity ratio of 2.38. The stock has a market cap of $17.12 billion, a price-to-earnings ratio of 25.57, a price-to-earnings-growth ratio of 3.35 and a beta of 0.86. The company has a 50-day moving average price of $268.11 and a two-hundred day moving average price of $294.03.
Institutional Trading of Waters
Large investors have recently added to or reduced their stakes in the company. ANTIPODES PARTNERS Ltd acquired a new stake in Waters in the first quarter valued at approximately $25,000. PSI Advisors LLC bought a new stake in Waters during the 2nd quarter worth approximately $26,000. Cascade Investment Advisors Inc. acquired a new stake in shares of Waters in the 1st quarter valued at approximately $31,000. Clear Street Markets LLC increased its position in Waters by 94.9% during the 1st quarter. Clear Street Markets LLC now owns 115 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 56 shares during the period. Finally, Graham Capital Wealth Management LLC acquired a new stake in Waters in the first quarter valued at about $387,038,000. 90.09% of the stock is owned by institutional investors and hedge funds.
About Waters
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- Space Investment: How to Invest in Space Exploration
- 3 Best Meme ETFs to Buy Now
- Are Stock Buybacks Good for the Average Investor?
- XPO Keeps Reaching New Highs: Markets Love the Stock
- What is Put Option Volume?
- Starbucks Market at a Turning Point: Is a Breakout Imminent?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.